CJC-1295 with DAC Peptide – Long-Acting GHRH Analog for Research
CJC-1295 with DAC (DAC:GRF) is a synthetic long-acting analog of growth hormone-releasing hormone (GHRH). The peptide incorporates a Drug Affinity Complex (DAC) modification and is supplied as a lyophilized research compound for laboratory, analytical, and biopharmaceutical research applications.
CJC-1295 with DAC has the molecular formula C165H269N47O46 and a molecular weight of approximately 3647.2 g/mol.
Product Specifications
- Product Name: CJC-1295 with DAC
- Synonyms: CJC1295 DAC, DAC:GRF, long-acting GHRH analog
- CAS Number: 446262-90-4
- Molecular Formula: C165H269N47O46
- Molecular Weight: 3647.2 g/mol
- Purity: ≥98% by HPLC
- Form: Lyophilized solid
- Grade: HPLC / Research
- Storage: Store at -20°C
- Availability: Made to order
- Documentation: COA, HPLC and MS documentation available according to batch specification
Research Applications
CJC-1295 with DAC is supplied for controlled laboratory research involving GHRH receptor signaling, peptide stability, pharmacokinetic research models, peptide–protein interactions, and investigations related to the GH/IGF-1 signaling axis.
It may also be used as a reference or analytical research material in peptide characterization, method development, and related biochemical studies.
Quality and Documentation
Each production batch can be supplied with analytical documentation according to the agreed product specification. Available documentation may include Certificate of Analysis (COA), HPLC purity data, mass spectrometry identity testing, and product specification information.
Custom synthesis, vial filling, OEM/ODM packaging, labeling, and bulk quantities are available for qualified research and biopharmaceutical customers.
Important Notice
For research and manufacturing use only. Not intended for human or veterinary use, personal consumption, diagnosis, treatment, or therapeutic applications. Supplied to qualified businesses and research organizations in accordance with applicable regulations.
